日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer

FoundationOne液体CDx检测结直肠癌BRAFV600E突变的临床有效性

Yaeger, Rona; Martini, Jean-François; Pasquina, Lincoln; Tunquist, Brian; Zhang, Xiaosong; Kaiser, Fatima; Pantoja Galicia, Norberto; Deng, Shibing; Gong, Siliang; Guo, Cui; Kiely, Jimmy; Ng, Ta-Chou Vincent; Ferrier, Graham; Tabernero, Josep; Kopetz, Scott

Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma

菲拉尼西布联合硼替佐米和地塞米松治疗复发/难治性t(11;14)和1q21扩增型多发性骨髓瘤

Pan, Darren; Kaufman, Jonathan L; Htut, Myo; Agrawal, Manish; Mazumder, Amitabha; Cornell, Robert F; Zonder, Jeffrey A; Fay, Joseph W; Modiano, Manuel R; Moshier, Erin L; Rush, Selena A; Tunquist, Brian J; Chari, Ajai

The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma

驱动蛋白纺锤体蛋白抑制剂filanesib可增强泊马度胺和地塞米松在多发性骨髓瘤中的活性。

Hernández-García, Susana; San-Segundo, Laura; González-Méndez, Lorena; Corchete, Luis A; Misiewicz-Krzeminska, Irena; Martín-Sánchez, Montserrat; López-Iglesias, Ana-Alicia; Algarín, Esperanza Macarena; Mogollón, Pedro; Díaz-Tejedor, Andrea; Paíno, Teresa; Tunquist, Brian; Mateos, María-Victoria; Gutiérrez, Norma C; Díaz-Rodriguez, Elena; Garayoa, Mercedes; Ocio, Enrique M

Cytotoxic efficacy of filanesib and melphalan combination is governed by sequence of treatment in human myeloma cells

在人类骨髓瘤细胞中,filanesib 和 melphalan 联合用药的细胞毒性疗效取决于治疗顺序。

Norris, E J; DeStephanis, D; Tunquist, B; Usmani, S; Ganapathi, R; Ganapathi, M

Protein Kinase A Opposes the Phosphorylation-dependent Recruitment of Glycogen Synthase Kinase 3β to A-kinase Anchoring Protein 220

蛋白激酶 A 阻止糖原合酶激酶 3β 磷酸化依赖性募集至 A-激酶锚定蛋白 220

Jennifer L Whiting, Patrick J Nygren, Brian J Tunquist, Lorene K Langeberg, Ole-Morten Seternes, John D Scott

Anchored protein kinase A recruitment of active Rac GTPase

锚定蛋白激酶A募集活性Rac GTP酶

Logue, Jeremy S; Whiting, Jennifer L; Tunquist, Brian; Langeberg, Lorene K; Scott, John D

Spindle checkpoint proteins Mad1 and Mad2 are required for cytostatic factor-mediated metaphase arrest

纺锤体检查点蛋白 Mad1 和 Mad2 是细胞抑制因子介导的中期停滞所必需的

Brian J Tunquist, Patrick A Eyers, Lin G Chen, Andrea L Lewellyn, James L Maller